Notice to Attend the Annual General Meeting of IRRAS AB (publ)
STOCKHOLM, April 15, 2019 /PRNewswire/ -- The shareholders in IRRAS AB (publ), reg. no. 556872-7134, are hereby invited to attend the annual general meeting ("AGM") to be held on Tuesday 14 May 2019 at 12.00 noon at IVA Konferenscenter, Grev Turegatan 16 in Stockholm, Sweden.
Notification to attend etc.
Shareholders who wish to attend the AGM must
- be recorded in the share register kept by Euroclear Sweden AB no later than on Wednesday 8 May 2019; and
- notify the company of their intention to attend the AGM at the latest by Thursday 9 May 2019.
Notification to participate in the AGM must be in writing via the booking form available on the company's website www.irras.com or by e-mail to AGM2019@irras.com. Notification can also be made by telephone at +46 10 211 51 70. The notification shall state name, personal identification number/ company registration number, address, telephone number and number of shares held.
Shareholders represented by proxy must issue a written, signed and dated proxy. If the proxy is issued by a legal entity, a certified copy of the valid registration certificate (Sw. registreringsbevis) of the legal entity (or similar document for non-Swedish legal entity) must be attached to the proxy. The proxy may not be older than one year unless it states that it is valid for a longer period of time (the validity of the proxy may not exceed five years).
In order to facilitate the registration, proxies in its original as well as registration certificates and other authorization documents should be sent to the company address, IRRAS AB (publ), Att: Sabina Berlin, Vasagatan 16, SE-111 20 Stockholm, Sweden well in advance before the meeting.
Proxy forms for shareholders who wish to attend the meeting by proxy will be available on the company website, www.irras.com.
Shareholding in the name of a nominee
In order to be entitled to participate in the meeting, shareholders who hold their shares through nominees (Sw. förvaltare) must request a temporary registration of the shares in their own name, with Euroclear Sweden AB. Shareholders who wishes to obtain such registration must contact the nominee regarding this well in advance of 8 May 2019.
Proposal for agenda
- Opening of the meeting
- Election of chairman of the meeting
- Preparation and approval of the voting list
- Approval of the agenda
- Election of one or two persons to approve the minutes
- Determination as to whether the meeting has been duly convened
- Presentation of the annual report and the auditor's report as well as the consolidated annual report and the auditor's report on the consolidated annual report
- Statement by the CEO
- Adoption of the profit and loss statement and the balance sheet as well as the consolidated profit and loss statement and the consolidated balance sheet
- Resolution in respect of appropriation of the company's profit or loss as set forth in the adopted balance sheet
- Resolution in respect of discharge of the board members and the CEO from liability
- Determination of number of board members and auditors
- Determination of fees for board members and auditors
- Election of board members and Chairman of the Board of Directors
- Election of auditor
- Resolution in respect of guidelines for remuneration for senior executives
- Resolution in respect of authorization for the Board of Directors to issue shares and/or convertible bonds
- Closing of the meeting
Proposals by the Nomination Committee
The Nomination Committee has consisted of Christer Hellström, Chairman of the Nomination Committee, appointed by Bacara Holdings Limited, Anders P. Wiklund, Chairman of the Board of Directors of IRRAS AB, Marios Fotiadis, appointed by Lexington Holding Assets Limited (BVI) and Christos Panotopoulos, appointed by F.EX Endotherapy Limited.
Election of Chairman of the Meeting (item 2)
The Nomination Committee proposes that Anders P. Wiklund is elected as Chairman of the Meeting.
Determination of number of board members and auditors (item 12)
The Nomination Committee proposes that the Board of Directors shall consist of five board members elected by the General Meeting. The nomination committee also proposes that the Company shall have one registered auditing company as auditor.
Determination of fees for board members and auditors (item 13)
The Nomination Committee proposes that the total remuneration for the Board of Directors shall amount to SEK 1,360,000, of which SEK 540,000 shall be paid to the Chairman of the Board of Directors and SEK 240,000 shall be paid to each of the other board members elected by the General Meeting and who are not employees of the group. The Nomination Committee proposes that a fee of SEK 100,000 shall be paid to the Chairman of the Audit Committee and the Remuneration Committee, respectively, and that a fee of SEK 50,000 shall be paid to each of the other members of the Committees. The total remuneration of SEK 1,360,000 as set out above assumes that the Audit Committee consists of two members and the Remuneration Committee consists of three members.
The Nomination Committee proposes that the audit fees shall be paid in accordance with approved invoices.
Election of board members and Chairman of the Board of Directors (item 14)
As members of the Board of Directors until the end of the next Annual General Meeting, the Nomination Committee proposes re-election of Anders P. Wiklund, Kleanthis G. Xanthopoulos, Marios Fotiadis, Anita Tollstadius and Eva Nilsagård. The Nomination Committee further intends to propose an additional Board member, who will be presented as soon as possible and no later than in connection with the Annual General Meeting. Board member Saeid Esmaeilzadeh has declined to be re-elected.
The Nomination Committee proposes re-election of Anders P. Wiklund as the Chairman of the Board of Directors.
Election of auditor (item 15)
The Nomination Committee proposes that the registered auditing company KPMG AB shall be re-elected as auditor for the period until the next AGM. KPMG AB has informed that, if KPMG AB is re-elected as auditor, the authorised public accountant Duane Swanson will continue as the responsible auditor. The Nomination Committee's proposal is recommended by the Company's Audit Committee.
Proposals by the Board of Directors
Dividend (item 10)
The Board of Directors proposes that the AGM shall resolve not to distribute any dividends for the financial year 2018.
Resolution in respect of guidelines for remuneration of senior management (item 16)
The Board of Directors proposes that the AGM decides on guidelines for remuneration and other terms of employment for senior executives according to the following.
The Company's starting point is that salary and other terms and conditions shall enable the group to attract and retain qualified management persons at a reasonable cost for the Company. The remuneration for management persons shall be decided in accordance with IRRAS remuneration policy. The remuneration for management persons consist of fixed salary, variable remuneration, pension and other benefits. In order to avoid that the management persons take unnecessary risks there shall be a fundamental balance between fixed and variable remuneration. Furthermore, the annual general meeting in IRRAS may, if so is ordered, offer long-term incentive schemes such as share or share price related incentive schemes.
Each management person shall be offered a market level fixed salary based on the degree of difficulty, responsibilities, experience and performance. In addition, each management person may from time to time, be offered a variable remuneration (bonus) to be paid in cash. The variable remuneration shall be based on clear predetermined and measurable performance criteria and economic results, as well as predetermined individual objectives and business objectives, and shall also be designed to promote IRRAS long-term value creation. Variable remuneration may not exceed 12 months' fixed salary.
Management persons shall be offered pension terms that are in accordance with market practice in the country where the management persons habitually resides. Non-monetary benefits shall facilitate the work of the management persons and shall correspond to what is considered reasonable in relation to market practice. The fixed salary during the notice period shall, together with severance pay, not exceed 24 months' fixed salary. Insofar board members who are elected by the General Meeting carry out work in addition to work on the Board of Directors, it shall be possible to remunerate them for such work. The remuneration shall be in accordance with market terms and shall be approved by the Board of Directors.
The Board of Directors shall, before every Annual General Meeting, consider whether or not additional share or share price-related incentive schemes shall be proposed to the General Meeting. It is the General Meeting that resolves upon such incentive schemes. Incentive schemes shall promote long-term value growth. New share issues and transfers of securities resolved upon by the general meeting in accordance with the rules of Chapter 16 of the Swedish Companies Act are not covered by the guidelines to the extent the Annual General Meeting has taken, or will take, such decisions.
The Board of Directors shall be entitled to deviate from the guidelines in individual cases if there are special reasons for doing so.
Resolution in respect of authorization for the Board of Directors to resolve to issue of shares and/or convertible bonds (item 17)
The Board of Directors proposes that the AGM authorizes the Board of Directors to, on one or several occasions during the period until the next AGM, with or without deviation from the shareholders' preferential rights, resolve on share issues and/or issues of convertible bonds.
The purpose of the authorization and the reason for the deviation from the shareholders' preferential rights, if any, is to enable the Company to carry out issues of shares and/or convertible bonds in a time-efficient way to finance acquisitions or investments in new or existing businesses. The issuance of shares or convertible bonds under the authorisation shall, in case of deviation from the shareholders' preferential rights, be made at a subscription price according to the prevailing market conditions at the time of the issuance of the shares and/or convertible bonds. Payment for subscribed shares and/or convertible bonds shall be made in cash, in kind or by way of set-off.
The Board of Directors' complete proposal will be available as set out in section "Documents" below no later than on 23 April 2019.
A valid resolution by the General Meeting pursuant to the proposal above requires that the resolution be supported by shareholders representing at least two-thirds of both the votes cast and the shares represented at the General Meeting.
Number of shares and votes
As per 15 April 2019, the total number of shares and votes in the Company amounts to 24,017,974. Currently, the Company holds no own shares.
The Nomination Committee's reasoned statement regarding the proposals relating to the Board of Directors and information regarding the proposed board members are available at the Company's website, www.irras.com and at the Company's office at Vasagatan 16 in Stockholm, and will be sent free of charge to shareholders who so request and provide their postal address or email address. The complete proposal pursuant to item 17 above, and the annual report and the audit report, will be available at the Company's website and at the Company's office at the address set out above no later than on 23 April 2019.
The shareholders' right to submit questions
The board and the CEO shall, if any shareholder so requests and the board believes that it may be done without significantly harming the company, provide information regarding circumstances that may affect the assessment of an item on the agenda, circumstances that can affect the assessment of the company's or its subsidiaries' financial position and the company's relationship to other companies within the group as well as the consolidated financial statements. Anyone wishing to submit questions in advance can do so by sending them to the company at the address mentioned above.
Stockholm, April 2019
IRRAS AB (PUBL)
The Board of Directors
For more information, please contact:
Kleanthis G. Xanthopoulos, Ph.D.
President & CEO
CFO and Deputy CEO
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
NOTICE TO ATTEND THE ANNUAL GENERAL MEETING OF IRRAS AB (PUBL) (PDF)
Upcoming Life Sciences Events
- September 2019
- Boston: 9th Annual American Drug Delivery & Formulation Summit
- Malmo: NLS Days 2019
- Boston: Redefining Early Stage Investments (RESI)
Latest company news
There are currently no news available for this portal